Acetylcarnitine increases membrane cytoskeletal protein-protein interactions

This publication has 24 references indexed in Scilit:

• Advances in Alzheimer's disease
  The FASEB Journal, 1991
• Structural aspects of pathology in Alzheimer's disease
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1990
• Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary Findings
  The Journal of Clinical Pharmacology, 1990
• Structure-activity investigation of the alteration of the physical state of the skeletal network of proteins in human erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridine
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1990
• Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia
  Current Medical Research and Opinion, 1990
• Spin-Labelling Studies of the Interaction of 9-Amino-1,2,3,4-Tetrahydroacridine (Tha), A Proposed Drug for the Treatment of Alzheimer's Disease, with Erythrocyte Membranes
  Free Radical Research Communications, 1990
• Multicenter clinical placebo‐controlled study with acetyl‐l‐carnitine (LAC) in the treatment of mildly demented elderly patients
  Drug Development Research, 1988
• Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
  New England Journal of Medicine, 1986
• DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE
  The Lancet, 1986
• Presynaptic Cholinergic Dysfunction in Patients with Dementia
  Journal of Neurochemistry, 1983